ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC38871-25mg |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |
GC38871-10mg |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |
GC38871-5mg |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |
GC38871-1mg |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |
GC38871-10mM (in 1mL DMSO) |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |
GC38870-100mg |
|
2098799-80-3 |
VH032-PEG3-acetylene
|
0 | C31H42N4O7S | |
GC38870-50mg |
|
2098799-80-3 |
VH032-PEG3-acetylene
|
0 | C31H42N4O7S | |
GC38870-25mg |
|
2098799-80-3 |
VH032-PEG3-acetylene
|
0 | C31H42N4O7S | |
GC38870-10mg |
|
2098799-80-3 |
VH032-PEG3-acetylene
|
0 | C31H42N4O7S | |
GC38870-5mg |
|
2098799-80-3 |
VH032-PEG3-acetylene
|
0 | C31H42N4O7S | |
GC38870-10mM (in 1mL DMSO) |
|
2098799-80-3 |
VH032-PEG3-acetylene
|
0 | C31H42N4O7S | |
GC38869-10mg |
|
— |
Transdermal Peptide TFA
|
0 | C42H65F3N14O18S2 | |
GC38869-5mg |
|
— |
Transdermal Peptide TFA
|
0 | C42H65F3N14O18S2 | |
GC38869-1mg |
|
— |
Transdermal Peptide TFA
|
0 | C42H65F3N14O18S2 | |
GC38868-50mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002
|
0 | C17H17NO | |
GC38868-25mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002
|
0 | C17H17NO | |
GC38868-10mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002
|
0 | C17H17NO | |
GC38868-5mg |
|
433249-94-6 |
TRAF-STOP inhibitor 6877002
|
0 | C17H17NO | |
GC38867-100mg |
|
217817-01-1 |
Tos-PEG4-t-butyl ester
|
0 | C20H32O8S | |
GC38867-50mg |
|
217817-01-1 |
Tos-PEG4-t-butyl ester
|
0 | C20H32O8S | |